GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R/AMPK pathway

Biology of Incretins: GLP-1 and GIP

Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · see citing works

Fiber Types in Mammalian Skeletal Muscles

Schiaffino, S., & Reggiani, C. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2010 · Cited by 3,022 · see citing works

Glucagon-like peptide 1 (GLP-1)

Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · see citing works

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922 · see citing works

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906 · see citing works

Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium

Gribble, F. M., & Reimann, F. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105439 · Cited by 683 · see citing works

Function and mechanisms of enteroendocrine cells and gut hormones in metabolism

Gribble, F. M., & Reimann, F. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0168-8 · Cited by 670 · see citing works

Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease

Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498 · see citing works

Identification and characterization of GLP-1 receptor–expressing cells using a new transgenic mouse model

Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., & Reimann, F. (2014) · Diabetes · doi:10.2337/db13-1440 · Cited by 472 · see citing works

Current Protocols in Microbiology

(2005) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9780471729259 · Cited by 407 · see citing works

Effects of exercise on gut peptides, energy intake and appetite

Martins, C., Morgan, L., Bloom, S. R., & Robertson, M. D. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0030 · Cited by 356 · see citing works

GLP-1 Receptor Expression Within the Human Heart

Baggio, L. L., Yusta, B., Mulvihill, E. E., Cao, X., Streutker, C. J., Butany, J., Cappola, T. P., Margulies, K. B., & Drucker, D. J. (2018) · Endocrinology · doi:10.1210/en.2018-00004 · Cited by 312 · see citing works

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302 · see citing works

Mitochondrial Dynamics Is a Distinguishing Feature of Skeletal Muscle Fiber Types and Regulates Organellar Compartmentalization

Mishra, P., Varuzhanyan, G., Pham, A. H., & Chan, D. C. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.027 · Cited by 290 · see citing works

Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health?

Cerdá, B., Pérez, M., Pérez-Santiago, J. D., Tornero-Aguilera, J. F., González-Soltero, R., & Larrosa, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00051 · Cited by 247 · see citing works

Metabolic messengers: glucagon-like peptide 1

Gribble, F. M., & Reimann, F. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00327-x · Cited by 199 · see citing works

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy

Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188 · see citing works

Exercise Mimetics: Impact on Health and Performance

Fan, W., & Evans, R. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.022 · Cited by 188 · see citing works

Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease

He, S., Kahles, F., Rattik, S., Nairz, M., McAlpine, C. S., Anzai, A., Selgrade, D. F., Fenn, A. M., Chan, C. T., Mindur, J. E., et al. (2019) · Nature · doi:10.1038/s41586-018-0849-9 · Cited by 169 · see citing works

Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line1

BRUBAKER, P. L., Schloos, J., & Drucker, D. J. (1998) · Endocrinology · doi:10.1210/endo.139.10.6228 · Cited by 168 · see citing works

Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice

Allen, J. M., Mailing, L. J., Cohrs, J., Salmonson, C., Fryer, J. D., Nehra, V., Hale, V. L., Kashyap, P., White, B. A., & Woods, J. A. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1372077 · Cited by 152 · see citing works

Metabolic Effects of Exercise

Moghetti, P., Bacchi, E., Brangani, C., Donà, S., & Negri, C. (2016) · Frontiers of hormone research · doi:10.1159/000445156 · Cited by 133 · see citing works

Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study

Perna, S., Guido, D., Bologna, C., Solerte, S. B., Guerriero, F., Isu, A., & Rondanelli, M. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0525-y · Cited by 125 · see citing works

Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges

Ghislain, J. J., & Poitout, V. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00459-w · Cited by 107 · see citing works

Diabetes pharmacotherapy and effects on the musculoskeletal system

Kalaitzoglou, E., Fowlkes, J. L., Popescu, I. R., & Thrailkill, K. M. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3100 · Cited by 101 · see citing works

Perspectives in GLP-1 Research: New Targets, New Receptors

Cantini, G., Mannucci, E., & Luconi, M. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.017 · Cited by 89 · see citing works

The Interplay Between Exercise Metabolism, Epigenetics, and Skeletal Muscle Remodeling

Seaborne, R. A. E., & Sharples, A. P. (2020) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000227 · Cited by 81 · see citing works

Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia

Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044284 · Cited by 80 · see citing works

Non-shivering Thermogenesis Signalling Regulation and Potential Therapeutic Applications of Brown Adipose Tissue

Zhang, Z., Yang, D., Xiang, J., Zhou, J., Cao, H., Che, Q., Bai, Y., Guo, J., & Su, Z. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60354 · Cited by 80 · see citing works

Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents

Gurjar, A. A., Kushwaha, S., Chattopadhyay, S., Das, N., Pal, S., China, S. P., Kumar, H., Trivedi, A. K., Guha, R., Chattopadhyay, N., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2019.154044 · Cited by 79 · see citing works

Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling

Takada, S., Masaki, Y., Kinugawa, S., Matsumoto, J., Furihata, T., Mizushima, W., Kadoguchi, T., Fukushima, A., Homma, T., Takahashi, M., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw182 · Cited by 78 · see citing works

Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice

Xirouchaki, C. E., Mangiafico, S. P., Bate, K. L., Ruan, Z., Huang, A. M., Tedjosiswoyo, B. W., Lamont, B. J., Pong, W., Favaloro, J. M., Blair, A. R., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.004 · Cited by 68 · see citing works

Appetite, food intake and gut hormone responses to intense aerobic exercise of different duration

Holliday, A., & Blannin, A. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0570 · Cited by 62 · see citing works

Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells

Li, Z., Ni, C.-L., Yao, Z., Chen, L.-M., & Niu, W.-Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.008 · Cited by 56 · see citing works

Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.

Liu, J., Hu, Y., Zhang, H., Xu, Y., & Wang, G. (2016) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2016.07.020 · Cited by 51 · see citing works

Saxagliptin Restores Vascular Mitochondrial Exercise Response in the Goto-Kakizaki Rat

Keller, A. C., Knaub, L. A., Miller, M. W., Birdsey, N., Klemm, D. J., & Reusch, J. E. B. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000170 · Cited by 49 · see citing works

Myricetin improves endurance capacity by inducing muscle fiber type conversion via miR-499

Wu, L., Ran, L., Lang, H., Zhou, M., Yu, L., Yi, L., Zhu, J., Liu, L., & Mi, M. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0353-8 · Cited by 31 · see citing works

Gene Transfer in Skeletal and Cardiac Muscle Using Recombinant Adeno‐Associated Virus

Gruntman, A. M., Bish, L. T., Mueller, C., Sweeney, H. L., Flotte, T. R., & Gao, G. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc14d03s28 · Cited by 25 · see citing works

GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?

Nauck, M. A., & Meier, J. J. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30043-7 · Cited by 24 · see citing works

Glucagon-like peptide-1 receptor antagonism impairs basal exercise capacity and vascular adaptation to aerobic exercise training in rats

Scalzo, R. L., Knaub, L. A., Hull, S., Keller, A. C., Hunter, K. S., Walker, L. A., & Reusch, J. E. B. (2018) · Physiological Reports · doi:10.14814/phy2.13754 · Cited by 17 · see citing works

Untitled work

Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036 · see citing works

Changes in lean body mass with <scp>glucagon‐like peptide</scp> ‐1‐based therapies and mitigation strategies

Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15728 · Cited by 391 · see citing works

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis

Karakasis, P., Patoulias, D., Fragakis, N., & Mantzoros, C. S. (2025) · Metabolism · doi:10.1016/j.metabol.2024.156113 · Cited by 242 · see citing works

Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?

Linge, J., Birkenfeld, A. L., & Neeland, I. J. (2024) · Circulation · doi:10.1161/circulationaha.124.067676 · Cited by 180 · see citing works

Mechanism of action of the bile acid receptor TGR5 in obesity

Lun, W., Yan, Q., Guo, X., Zhou, M., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.011 · Cited by 117 · see citing works

Skeletal muscle mitochondrial remodeling in heart failure: An update on mechanisms and therapeutic opportunities

Lv, J., Li, Y., Shi, S., Xu, X., Wu, H., Zhang, B., & Song, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113833 · Cited by 73 · see citing works

Spotlight on the Mechanism of Action of Semaglutide

Papakonstantinou, I. P., Tsioufis, K. P., & Katsi, V. K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120872 · Cited by 80 · see citing works

Glucagon-like peptide-1 receptor agonists and muscle mass effects

Ceasovschih, A., Asaftei, A., Lupo, M. G., Kotlyarov, S., Bartušková, H., Balta, A., Sorodoc, V., Sorodoc, L., & Banach, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107927 · Cited by 64 · see citing works

Impact of GLP-1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia

Memel, Z., Gold, S. L., Pearlman, M., Muratore, A., & Martindale, R. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00649-w · Cited by 63 · see citing works

Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis

Jiao, R., Lin, C., Cai, X., Wang, J., Wang, Y., Lv, F., Yang, W., & Ji, L. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16012 · Cited by 60 · see citing works

Autolysosomal Dysfunction in Obesity-induced Metabolic Inflammation and Related Disorders

Cheong, L. Y. T., Saipuljumri, E. N., Loi, G. W. Z., Zeng, J., & Lo, C. H. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00638-8 · Cited by 57 · see citing works

The effects of GLP-1 agonists on musculoskeletal health and orthopedic care

Gatto, A., Liu, K., Milan, N., & Wong, S. (2025) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-025-09978-3 · Cited by 55 · see citing works

Physical Exercise as Disease-Modifying Alternative against Alzheimer’s Disease: A Gut–Muscle–Brain Partnership

Cutuli, D., Decandia, D., Giacovazzo, G., & Coccurello, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914686 · Cited by 58 · see citing works

Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice

Iwai, S., Kaji, K., Nishimura, N., Kubo, T., Tomooka, F., Shibamoto, A., Suzuki, J., Tsuji, Y., Fujinaga, Y., Kitagawa, K., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166770 · Cited by 55 · see citing works

<scp>Glucagon‐like peptide</scp> ‐1 <scp>receptor agonist</scp> ‐based agents and weight loss composition: Filling the gaps

Dubin, R. L., Heymsfield, S. B., Ravussin, E., & Greenway, F. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15913 · Cited by 47 · see citing works

Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: A review of current evidence and future directions

Bılgın, E., Venerito, V., & Bogdanos, D. P. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103864 · Cited by 45 · see citing works

Role of the gut–muscle axis in mitochondrial function of ageing muscle under different exercise modes

Xie, X., & Huang, C. X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102316 · Cited by 37 · see citing works

Adipose tissue in older individuals: a contributing factor to sarcopenia

Wang, T., Zhou, D., & Hong, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155998 · Cited by 35 · see citing works

Geniposide stimulates autophagy by activating the GLP-1R/AMPK/mTOR signaling in osteoarthritis chondrocytes

Huang, J., Chen, Z., Wu, Z., Xie, X., Liu, S., Kong, W., & Zhou, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115595 · Cited by 32 · see citing works

Dietary Strategies to Improve Exercise Performance by Modulating the Gut Microbiota

Zhang, L., Li, H., Song, Z., Liu, Y., & Zhang, X. (2024) · Foods · doi:10.3390/foods13111680 · Cited by 33 · see citing works

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy

Januzzi, J. L., Butler, J., Prato, S. D., Ezekowitz, J. A., Ibrahim, N. E., Lam, C. S. P., Lewis, G. D., Marwick, T. H., Perfetti, R., Rosenstock, J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.380 · Cited by 29 · see citing works

Unlocking Longevity with GLP-1: A Key to Turn Back the Clock?

Chavda, V. P., Balar, P. C., Vaghela, D. A., & Dodiya, P. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108028 · Cited by 24 · see citing works

Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway

Chen, K., Jin, H., Wu, Z., Zhang, B., Wu, J., Huang, Z., Huang, Y., Lu, X., & Zheng, X.-T. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00817-8 · Cited by 24 · see citing works

Semaglutide ameliorates osteoarthritis progression through a weight loss-independent metabolic restoration mechanism

Qin, H., Yu, J., Yu, H., Zhou, C., Yuan, D., Wang, Z., Zhu, Z., Wei, G., Ou, P., Li, Z., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.01.008 · Cited by 24 · see citing works

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans

Langer, H. T., Gilmore, N. K., Hayden, C. M. T., Roux, J., Bariohay, B., Rouquet, T., Awada, M., Marcotorchino, J., Bournot, L., Nunn, E., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102665 · Cited by 21 · see citing works

Effect of GLP-1 receptor agonists on body composition

Bhandarkar, A. P., Bhat, S., & Kapoor, N. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000934 · Cited by 25 · see citing works

The Potential of the Flavonoid Content of Ipomoea batatas L. as an Alternative Analog GLP-1 for Diabetes Type 2 Treatment—Systematic Review

Dewi, N. K. S. M., Ramona, Y., Saraswati, M. R., Wihandani, D. M., & Wirasuta, I. M. A. G. (2023) · Metabolites · doi:10.3390/metabo14010029 · Cited by 21 · see citing works

New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review

Jalil, J., Gabrielli, L., Ocaranza, M. P., MacNab, P., Fernández, R., Grassi, B. A., Jofré, P., Verdejo, H., Mónica Acevedo, B., Samuel Córdova, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084407 · Cited by 21 · see citing works

A review of the functional activities of chia seed and the mechanisms of action related to molecular targets

Chen, J., Wu, G., Zhu, L., Karrar, E. M. A., & Zhang, H. (2024) · Food & Function · doi:10.1039/d3fo02197a · Cited by 20 · see citing works

GLP-1R activation restores Gas6-driven efferocytosis in senescent foamy macrophages to promote neural repair

Xia, M., Li, C., Zhang, Y., Wang, T., Zhang, C., Zhou, J., Zhu, X., Hong, H., Li, H., Qian, Z., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103857 · Cited by 19 · see citing works

Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatment

González-Luis, A., Llinares-Arvelo, V., Martínez‐Alberto, C. E., Hernández-Carballo, C., Fernández, C. M., Navarro‐González, J. F., & Donate‐Correa, J. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf223 · Cited by 19 · see citing works

Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance

De Fano, M., Malara, M., Vermigli, C., & Murdolo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168650 · Cited by 17 · see citing works

The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets

Reed, J., Bain, S. C., & Kanamarlapudi, V. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s415934 · Cited by 18 · see citing works

Incretin Receptor Agonism, Fat-free Mass, and Cardiorespiratory Fitness: A Narrative Review

Liu, Z., Weeldreyer, N. R., & Angadi, S. S. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf335 · Cited by 16 · see citing works

Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies

Julien, S., Challier, I., Malleter, M., Jouen, F., Drouot, L., & Boyer, O. (2024) · Antibodies · doi:10.3390/antib13010012 · Cited by 14 · see citing works

Effect and mechanism of GLP-1 on cognitive function in diabetes mellitus

Dou, X., Zhao, L., Li, J., & Jiang, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1537898 · Cited by 16 · see citing works

Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review

Barana, L., De Fano, M., Cavallo, M., Manco, M., Prete, D., Fanelli, C. G., Porcellati, F., & Pippi, R. (2025) · Nutrients · doi:10.3390/nu18010131 · Cited by 13 · see citing works

Frailty and Effects of Semaglutide in Obesity-Related HFpEF

Pandey, A., Kitzman, D. W., Chinnakondepalli, K., Patel, S., Borlaug, B. A., Butler, J., Davies, M. J., Shah, S. J., Verma, S., Rönnbäck, C., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2025.102610 · Cited by 13 · see citing works

Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet‐induced obesity

Jeromson, S., Baranowski, B., Akcan, M., Waters, B. D., Eisner, K., Bellucci, A., Trang, S., Abolhassani, A., Tello‐Palencia, M. A., Schweitzer, A. M., et al. (2025) · The Journal of Physiology · doi:10.1113/jp289449 · Cited by 13 · see citing works

TGR5 Activation by Dietary Bioactives and Related Improvement in Mitochondrial Function for Alleviating Diabetes and Associated Complications

He, Q., Li, X., Li, H., Tan, A., Chi, Y., Fang, D., Li, X., Liu, Z., Shang, Q., Zhu, Y. H., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c10395 · Cited by 12 · see citing works

GLP-1 and Its Role in Glycogen Production: A Narrative Review

Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 13 · see citing works

Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists

Llinares-Arvelo, V., Martínez‐Alberto, C. E., González-Luis, A., Macía-Heras, M., Siverio-Morales, O., Navarro‐González, J. F., & Donate‐Correa, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168096 · Cited by 13 · see citing works

Chickpea proteins are potential sources of bioactive peptides that induce glucose uptake via AMP-activated protein kinase

Oishi, S., Yoshioka, Y., Dohra, H., & Miyoshi, N. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104029 · Cited by 11 · see citing works

Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Idiopathic Inflammatory Myopathy: From Mechanisms of Action to Clinical Applications

Rajagopal, S., Alruwaili, F., Mavratsas, V., Serna, M. K., Murthy, V. L., & Raji, M. (2023) · Cureus · doi:10.7759/cureus.51352 · Cited by 11 · see citing works

Muscle health in the modern era of incretin‐based therapies

Girolamo, G. D., Sangineto, M., Gioia, G. D., Bianco, R., Ciarnelli, M., & Serviddio, G. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70155 · Cited by 11 · see citing works

The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition

Chrysavgis, L., Mourelatou, N. G., Koloutsou, M. E., Rozani, S., & Cholongitas, Ε. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412130 · Cited by 12 · see citing works

Transgenic sensors reveal compartment-specific effects of aggregation-prone proteins on subcellular proteostasis during aging

Curley, M., Rai, M., Chuang, C.-L., Pagala, V., Stephan, A., Coleman, Z., Robles‐Murguia, M., Wang, Y., Peng, J., & Demontis, F. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100875 · Cited by 10 · see citing works

Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy

Zaitoon, H., Lubetzky, R., Amir, A. Z., Moran‐Lev, H., Sagi, L., Bach, M. Y., Borger, O., Chorna, E., Lebenthal, Y., & Brener, A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02109-9 · Cited by 10 · see citing works

GLP-1R agonist therapy and vaccine response: Neglected implications

van Niekerk, G., Coelmont, L., Alpizar, Y. A., Kelchtermans, L., Broeckhoven, E., & Dallmeier, K. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.07.006 · Cited by 9 · see citing works

Mechanomedicine for Addressing Skeletal Muscle Insulin Resistance

Wang, L., Chang, L., Ma, Y., Jia, Y., Gao, B., Cui, W., & Xu, F. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf012 · Cited by 9 · see citing works

The role of glucagon-like peptides in osteosarcopenia

Tufail, E., Sanyal, S., Mithal, A., Sanyal, S., & Chattopadhyay, N. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0210 · Cited by 8 · see citing works

Exercise in atherosclerosis: its beneficial effects and underlying mechanism

Yin, M.-T., & Guo, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1598794 · Cited by 10 · see citing works

Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin

Chan, D., Lin, Y.-C., Tzeng, H.-P., Yang, R., Chiang, M., & Liu, S. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102479 · Cited by 8 · see citing works

Intestinal butyric acid-mediated disruption of gut hormone secretion and lipid metabolism in vasopressin receptor-deficient mice

Harada, K., Wada, E., Osuga, Y., Shimizu, K., Uenoyama, R., Hirai, M. Y., Maekawa, F., Miyazaki, M., Hayashi, Y. K., Nakamura, K., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102072 · Cited by 7 · see citing works

Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle‐secreted factors

Sammut, M. J., Thorne, B. R., & Melling, C. W. J. (2025) · Obesity · doi:10.1002/oby.24223 · Cited by 7 · see citing works

The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study

Huang, B., Zhang, Y., Ruan, G., Yu, X., Liu, Q., Zhang, M., Yu, M., Chen, A., Liang, Y. Z., Xie, L., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13614 · Cited by 6 · see citing works

Enteroendocrine peptides, growth, and the microbiome during the porcine weaning transition

Ramsay, T. G., Arfken, A. M., & Summers, K. L. (2022) · Animal Microbiome · doi:10.1186/s42523-022-00206-8 · Cited by 6 · see citing works

Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in β-arrestin 1/2 signaling

Lei, S., Meng, Q., Liu, Y., Liu, Q., Dai, A., Cai, X., Wang, M., Zhou, Q., Zhou, H., & Yang, D. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176419 · Cited by 6 · see citing works

Physiological and functional characterization for high‐throughput optogenetic skeletal muscle exercise assays

Heisser, R. H., Bu, A., Schwendeman, L., Rossy, T., Umashankar, P., Butty, V. L., & Raman, R. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70101 · Cited by 5 · see citing works

Mitochondrial Adaptations in Skeletal Muscle Following Incretin‐Based Therapies: In Vitro

Old, V. J., Davies, M. J., Denniff, M. J., Choudhary, P., Eastley, N. C., Ashford, R. U., & Watson, E. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70254 · Cited by 5 · see citing works

Diabetes Pharmacotherapy and its effects on the Skeletal Muscle Energy Metabolism

Yu, B., Wang, D., Zhou, J., Huang, R., Cai, T., Hu, Y., Zhou, Y., & Ma, J. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575299439240216081711 · Cited by 5 · see citing works

Recent advances in understanding the mechanisms in skeletal muscle of interaction between exercise and frontline antihyperglycemic drugs

Newsom, S. A., & Robinson, M. M. (2024) · Physiological Reports · doi:10.14814/phy2.16093 · Cited by 4 · see citing works

Preoperative GLP-1 Receptor Agonist Use and Postoperative Outcomes Following Operative Ankle Fracture Repair in Patients With Type 2 Diabetes: A National Database Study

White, C., Choudhury, A., Bollepalli, H., Kodra, J. D., Burton, A. T., & Kraus, J. C. (2025) · Foot & Ankle International · doi:10.1177/10711007251364187 · Cited by 5 · see citing works

AMPK-Mediated Multi-Organ Protective Effects of GLP-1 Receptor Agonists

Wang, X., & Wang, L. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100004 · Cited by 5 · see citing works

Glucagon‐Like Peptide‐1 Receptor Agonism and Muscle Health: Vascular and Myocellular Effects on Glucose and Protein Metabolism

Katsanos, C. S., Liu, Z.-Q., & Atherton, P. J. (2026) · Comprehensive Physiology · doi:10.1002/cph4.70126 · Cited by 6 · see citing works

Exploring receptors for pro-resolving and non-pro-resolving mediators as therapeutic targets for sarcopenia

Wang, T., Chen, S., Zhou, D., & Hong, Z. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156148 · Cited by 4 · see citing works

In Old Mice, Exercise Induces Inflammation and Fibrosis Unless Alk5‐Inhibitor and Oxytocin Are Used

Cruz, J. M. C., Yeung, H., Alzalzalee, R., Yang, Q., Kabir, H., McDonough, S. A., Mei, X., Conboy, M. J., & Conboy, I. M. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70054 · Cited by 3 · see citing works

Physiological regulation of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha in mitochondrial metabolism during physical exercises: a systematic review

Ayubi, N., Wibawa, J. C., Rizki, A. Z., Afandi, A., & Callixte, C. (2025) · Medicni perspektivi · doi:10.26641/2307-0404.2025.2.333361 · Cited by 3 · see citing works

The effect of Semaglutide on mitochondrial function and insulin sensitivity in a myotube model of insulin resistance

Spry, E. R., Travis, K. B., Ragland, K. J., Klein, A. J., Zimmerman, J. M., & Vaughan, R. A. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112629 · Cited by 3 · see citing works

The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions

Takahashi, R., Obi, Y., Kalantar-Zadeh, K., & Kovesdy, C. P. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001131 · Cited by 3 · see citing works

A novel peptide from Garden pea proteins activates AMP-activated protein kinase and enhances glucose uptake in C2C12 myotubes

Oishi, S., Yoshioka, Y., Dohra, H., & Miyoshi, N. (2025) · Food Nutrition · doi:10.1016/j.fnutr.2025.100023 · Cited by 3 · see citing works

Benefits of Supplementing a GLP-1 Type Medication With Physical Activity

Ablah, E. A., Imboden, M. T., Zendell, A. L., Hosking, M., Anderson, R. E., VanHoose, K., Peterson, N. E., Wojcik, J. R., Pronk, N. P., Harber, M., et al. (2025) · American Journal of Health Promotion · doi:10.1177/08901171251357130 · Cited by 3 · see citing works

Mechanisms of muscle atrophy in type 2 diabetes mellitus: factors dysregulating muscle protein synthesis and breakdown

Jeong, M., McColl, T. J., & Clarke, D. C. (2025) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2025-0017 · Cited by 4 · see citing works

Integrating bile acid metabolism into precision nutrition strategies for improved swine performance

Li, S., He, Y., Shaoyong, W., Wang, Y., & Jin, M. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.05.013 · Cited by 2 · see citing works

GPCR-Mediated Cell Intelligence: A Potential Mechanism for Survival and Long-Term Health

Craig, C. J., Boeringer, T., Pardo, M., Pozo, A. D., & Maudsley, S. R. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020127 · Cited by 2 · see citing works

GLP-1 receptor agonist suppresses fatty infiltration while improving range of motion and electromyographic function in a chronic rotator cuff tear rat model

Yoon, J. P., Park, S.-J., Kim, D.-H., Lee, H., Kim, J.-Y., Pham, D. T., Cho, C., & Chung, S. W. (2026) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2025.12.019 · Cited by 2 · see citing works

Research progress on the molecular mechanism and clinical evidence of glucagon-like peptide-1 receptor agonists in improving sarcopenia

Yang, Q., Wang, Y., Gao, G., Li, H., Gao, Y., & He, J. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02133-z · Cited by 2 · see citing works

Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases

Yang, W., Hao, C., Wang, N., Xie, J., Zhou, B., Yang, Z., Zheng, A., Wei, J., Li, C., Xie, C., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2661854 · Cited by 2 · see citing works

Semaglutide beyond weight loss: Mechanistic insights and functional paradoxes from the SEMALEAN study

Samajdar, S. S., & Joshi, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70242 · Cited by 1 · see citing works

Glucagon-Like Peptide-1 Receptor Agonists and Sodium Glucose Cotransporter-2 Inhibitors and Cardiorespiratory Fitness Interaction

Ni, D., Kokkinos, P. F., & Nylen, E. S. (2024) · Military Medicine · doi:10.1093/milmed/usae311 · Cited by 1 · see citing works

Visceral adiposity index (VAI) association with suicidal ideation among U.S. adults: a cross-sectional study using NHANES 2005–2018 data

Qing, G., Tu, J., He, H., Su, M., Chen, Y., Wei, B., Yang, Y., Zhang, B., & Yang, G. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01755-y · Cited by 1 · see citing works

GW8510 alleviates muscle atrophy and skeletal muscle dysfunction in mice through AMPK/PGC1α signaling

Chen, Y., Liu, Z., Chen, L., Yang, D., Xiao, M., Li, Z., & Xie, Z. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5569 · Cited by 1 · see citing works

Impact of an 8-week home-based resistance training and leisure-time physical activity on serum glucagon-like peptide-1 and microRNA-192 levels in children with type 1 diabetes: A randomized clinical trial

Nazari, M., Minasian, V., & Hovsepian, S. (2025) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_582_24

Sarcopenia and obesity: Two sides of the same coin. Incretin technologies in addressing the problem

Demidova, T. Y., Толмачева, К. А., & Прилепа, С. А. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-4-06

Innovations in the Management of Load-Related Pain Across the Knee

Frederickson, M., Ogunleye, T. D., & Lee, C. A. (2025) · Operative Techniques in Sports Medicine · doi:10.1016/j.otsm.2026.151208

Fast Quantitative Evaluation of the Amelioration Effect in MASLD During Semaglutide Treatment Using Ultrasound‐Derived Fat Fraction and Fat‐to‐Muscle Ratio

Huang, Y., Yang, R., Wang, Y., Lu, X., Wei, L., Cheng, R., Cheng, J., Qiu, Y., Wang, S., Li, B., et al. (2026) · Portal hypertension & cirrhosis · doi:10.1002/poh2.70035

Correlation between human composition analysis and risk of dyslipidemia in health examination

Han, L., Feng, Y. A., & Zhang, Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05646-7

Outcomes of primary rotator cuff repair in non-diabetic patients using glucagon-like peptide-1 (GLP-1) receptor agonists: A propensity-matched analysis

Martino, J. A., Oles, A. R., Rogalski, B. L., Eichinger, J. K., & Friedman, R. J. (2026) · Shoulder & Elbow · doi:10.1177/17585732261434004

Current Biological Approach to Improve Rotator Cuff Muscle Quality

Park, S.-J., Yoon, J., & Chung, S. (2026) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.2026.61.1.22

A comprehensive review of GLP-1 and aerobic training in cardiovascular disease management

Kordi, N., Kheirandish, R., Akraminia, P., Jung, F., & Karami, S. (2025) · Clinical Hemorheology and Microcirculation · doi:10.1177/13860291251414840

The Impact of GLP-1 Receptor Agonists on Outcomes in Nondiabetic Patients Undergoing Posterior Cervical Spine Surgery

Rivera, N., Bradley, T., Cottrill, E. J., Ray, E. J., Zachem, T. J., Crowell, K., Goodwin, C. R., & Erickson, M. M. (2026) · Clinical Spine Surgery A Spine Publication · doi:10.1097/bsd.0000000000002064

Ginsenoside Rd Ameliorates Glucose Metabolism by Regulating GLP-1/MAPK/NF-κB Signaling Pathway in db/db Mice

Wu, W., Guo, Y., Xia, Q., Wang, H., Dong, H., Lu, F., Zheng, C., & Fen, Y. (2026) · Planta Medica · doi:10.1055/a-2898-9988

Role of incretins in Alzheimer’s disease and their impact on behavioral aspects

Yang, J., Mao, T., & Gao, L. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004195

Incretins: From Gene Expression to Secretion and Action of GLP-1 and GIP

Lobato, C. B., & Holst, J. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00004-4

The Pleiotropic Therapeutic Perspectives of GLP-1 and GIP Receptor Agonists in Spinal Cord Injury: A Narrative Review

Zhang, S., Liu, S., Zhou, M., Wang, J., Zhang, Y., Zhong, H., & Ning, G. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06090-6

Mitochondrial-derived peptides (MDPs) activated by physical exercise as therapeutic targets for metabolic disorders: A systematic review

Ayubi, N., Wibawa, J. C., Kurnaz, M., & Komaini, A. (2026) · Physiology International · doi:10.1556/2060.2026.00863

Exerkine-Mediated Inter-Organ Crosstalk and Translational Perspectives in Metabolic Diseases

Zhou, B., Zhang, S., Zhang, Z., Ran, S., Guo, H., Wang, S., & Meng, H. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00752-1

Skeletal Muscle Effects of GLP 1 Receptor Agonists: Molecular Mechanisms and Comparative Insights on Semaglutide and Tirzepatide, a Narrative Review

Cautela, D., Valeria, I., Lombardi, A., Laratta, B., Castaldo, C. M., Balestrieri, M. L., Mocini, E., Migliaccio, S., & Tardito, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188057

EFFECTS OF SEMAGLUTIDE AND TIRZEPATIDE ON SKELETAL MUSCLE MASS AND SARCOPENIA RISK IN ADULTS WITH OBESITY OR OVERWEIGHT: A NARRATIVE REVIEW

Mokrzecki, S., Mamach, A., Bełc, E., Brzezińska, K., Aleksandrowicz, K., Grodzka, Z., Meszka, M., Król, M., Straszewska, A., Woźniak, A., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6230

Growth Hormones and Aging

Johnston, M. J., & Brown‐Borg, H. M. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_27-2

Role of AMP-Activated Protein Kinase in the Molecular Adaptation to Endurance Exercise

Winder, W. W., Taylor, E. B., & Thomson, D. M. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233798.62153.50 · Cited by 101 · see citing works

AMPK and PPARβ positive feedback loop regulates endurance exercise training-mediated GLUT4 expression in skeletal muscle

Koh, J., Hancock, C. R., Han, D.-H., Holloszy, J. O., Nair, K. S., & Dasari, S. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2018 · Cited by 39 · see citing works

Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes

Luque, M. A., González, N., Marquez, L., Acitores, A., Redondo, A., Morales, M., Valverde, I., & Villanueva-Penacarrillo, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730465 · Cited by 131 · see citing works

Effects of endurance training on gene expression of glucose and lipid metabolism-related factors in diabetes

Yu, S. (2014) · Zhongguo laonianxue zazhi

Glucagon‐Like Peptide‐1 Receptor Agonism and Muscle Health: Vascular and Myocellular Effects on Glucose and Protein Metabolism

Katsanos, C. S., Liu, Z.-Q., & Atherton, P. J. (2026) · Comprehensive Physiology · doi:10.1002/cph4.70126 · Cited by 6 · see citing works